Athira Pharma, Inc. (ATHA) Earnings History
Annual and quarterly earnings data from 2018 to 2025
Loading earnings history...
ATHA EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
ATHA Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
Download Data
Export ATHA earnings history in CSV or JSON format
Free sign-in required to download data
Athira Pharma, Inc. (ATHA) Earnings Overview
As of May 8, 2026, Athira Pharma, Inc. (ATHA) reported trailing twelve-month net income of -$129M, reflecting +2.0% year-over-year growth. The company earned $-6.80 per diluted share over the past four quarters.
Looking at the long-term picture, ATHA's historical earnings data spans multiple years. The company achieved its highest annual net income of -$5M in fiscal 2018.
Athira Pharma, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including SAVA (-$106M net income), ACIU (-$70M net income, -1971.6% margin), PRAX (-$327M net income), ATHA has comparable earnings metrics. Compare ATHA vs SAVA →
ATHA Earnings vs Peers
Earnings metrics vs comparable public companies
ATHA Historical Earnings Data (2018–2025)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$106M | -8.9% | -$102M | $-24.70 | - | - |
| 2024 | -$97M | +17.6% | -$101M | $-25.20 | - | - |
| 2023 | -$118M | -23.0% | -$125M | $-30.90 | - | - |
| 2022 | -$96M | -74.4% | -$104M | $-25.30 | - | - |
| 2021 | -$55M | -174.9% | -$64M | $-14.90 | - | - |
| 2020 | -$20M | -286.6% | -$20M | $-6.10 | - | - |
| 2019 | -$5M | -1.3% | -$5M | $-1.40 | - | - |
| 2018 | -$5M | - | -$5M | $-1.60 | - | - |
See ATHA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ATHA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ATHA vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonATHA — Frequently Asked Questions
Quick answers to the most common questions about buying ATHA stock.
Is ATHA growing earnings?
ATHA EPS of $-6.80 reflects slowing growth at +2.0%, below the 5-year CAGR of N/A. TTM net income is $-129M. Expansion rate has moderated.
What are ATHA's profit margins?
Athira Pharma, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are ATHA's earnings?
ATHA earnings data spans 2018-2025. The current earnings trend is +2.0% YoY. Historical data enables comparison across business cycles.